19
AbbVie Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is PANCRELIPASE (AMYLASE;LIPASE;PROTEASE), with a corresponding application number 20725.
With a dosage strength 180,000USP UNITS;36,000USP UNITS;114,000USP UNITS
Dosage Form Route CAPSULE, DELAYED RELEASE; ORAL
18
AbbVie Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is PANCRELIPASE (AMYLASE;LIPASE;PROTEASE), with a corresponding application number 20725.
With a dosage strength 120,000USP UNITS;24,000USP UNITS;76,000USP UNITS
Dosage Form Route CAPSULE, DELAYED RELEASE; ORAL
17
AbbVie Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is PANCRELIPASE (AMYLASE;LIPASE;PROTEASE), with a corresponding application number 20725.
With a dosage strength 30,000USP UNITS;6,000USP UNITS;19,000USP UNITS
Dosage Form Route CAPSULE, DELAYED RELEASE; ORAL
16
AbbVie Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is PANCRELIPASE (AMYLASE;LIPASE;PROTEASE), with a corresponding application number 20725.
With a dosage strength 15,000USP UNITS;3,000USP UNITS;9,500USP UNITS
Dosage Form Route CAPSULE, DELAYED RELEASE; ORAL
15
AbbVie Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is PANCRELIPASE (AMYLASE;LIPASE;PROTEASE), with a corresponding application number 20725.
With a dosage strength 60,000USP UNITS;12,000USP UNITS;38,000USP UNITS
Dosage Form Route CAPSULE, DELAYED RELEASE; ORAL